Follow
Aung M. Tun
Aung M. Tun
The University of Kansas Cancer Center
Verified email at kumc.edu
Title
Cited by
Cited by
Year
Copper deficiency anemia
ZW Myint, TH Oo, KZ Thein, AM Tun, H Saeed
Annals of hematology 97, 1527-1534, 2018
2592018
Protein S deficiency
A Gupta, AM Tun, K Gupta, F Tuma
322019
Checkpoint inhibitors plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials
AM Tun, KZ Thein, WL Thein, E Guevara
Future science OA 5 (9), FSO421, 2019
282019
Immunotherapy in Hodgkin and non-Hodgkin lymphoma: Innate, adaptive and targeted immunological strategies
AM Tun, SM Ansell
Cancer Treatment Reviews 88, 102042, 2020
242020
High-dose methotrexate is not associated with reduction in CNS relapse in patients with aggressive B-cell lymphoma: an international retrospective study of 2300 high-risk patients
KL Lewis, LH Jakobsen, D Villa, S Bobillo, KE Smedby, KJ Savage, ...
Blood 138, 181, 2021
212021
A rare concurrence of leiomyomatosis peritonealis disseminata, leiomyosarcoma of the pelvis and leiomyomatous nodule of the liver
AM Tun, NM Tun, K Zin Thein, EE Naing, S Giashuddin, M Shulimovich
Case Reports in Oncological Medicine 2016, 2016
212016
Pernicious anemia: fundamental and practical aspects in diagnosis
AM Tun, KZ Thein, ZW Myint, TH Oo
Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly …, 2017
152017
Invasive aspergillosis in a patient with stage III (or 3a or 3b) non-small-cell lung cancer treated with durvalumab
A Gupta, A Tun, K Ticona, A Baqui, E Guevara
Case Reports in Oncological Medicine 2019, 2019
142019
Vitamin B12 deficiency-related pseudo-thrombotic microangiopathy might be misdiagnosed and treated with plasma product therapy: review of the literature and analysis of the …
AM Tun, ZW Myint, CR Hernandez, E Guevara, KZ Thein, TH Oo
Blood 130, 5576, 2017
142017
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma
A Castellino, AM Tun, Y Wang, TM Habermann, RL King, KM Ristow, ...
Blood Cancer Journal 11 (1), 1-8, 2021
132021
Progression-free survival at 24 months as a landmark after autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma
AM Tun, S Maliske, Y Wang, DJ Inwards, TM Habermann, I Micallef, ...
Transplantation and cellular therapy 28 (9), 610-617, 2022
112022
Molecular genetics and the role of molecularly targeted agents in metastatic colorectal carcinoma
A Naeem, AM Tun, E Guevara
Journal of Gastrointestinal Cancer 51, 387-400, 2020
92020
A case of classic Kaposi sarcoma in an immunocompetent human immunodeficiency virus–negative Dominican man
K Gupta, A Tun, A Gupta, LB Berkowitz, R Anwar, Y Liu, E Guevara
SAGE Open Medical Case Reports 8, 2050313X20938249, 2020
82020
High-dose methotrexate as CNS prophylaxis in high-risk aggressive B-cell lymphoma
KL Lewis, LH Jakobsen, D Villa, KE Smedby, KJ Savage, TA Eyre, ...
Journal of Clinical Oncology 41 (35), 5376-5387, 2023
72023
Subcutaneous Mosunetuzumab Is Active and Has a Manageable Safety Profile in Patients with Previously Untreated, Low-Tumor Burden Follicular Lymphoma: Initial Results from the …
IW Flinn, LE Budde, AM Tun, JM Burke, B Anz, S Peles, JP Sharman, ...
Blood 142, 3029, 2023
52023
Updated meta-analysis of randomized controlled trials to evaluate the incidence of infection and pneumonia in patients with multiple myeloma treated with daratumumab
TW Htut, AM Tun, A Sultan, MA Win, S Swarup, EM Phyu, PP Hlaing, ...
Blood 134, 4771, 2019
52019
Mogamulizumab-associated rash (MAR) correlates with longer progression free survival in cutaneous T cell lymphoma (CTCL)
B Hu, S Atrash, L Cohen, SK Barta, Y Zhang, L Sokol, A Ayers, ...
Blood 140 (Supplement 1), 1488-1490, 2022
42022
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study
AM Tun, A Khurana, R Mwangi, BK Link, Y Wang, AL Feldman, ...
Blood advances 6 (17), 5210-5221, 2022
42022
Is chimeric antigen receptor T cell (CART) a destination procedure? Lower socioeconomic class who live farther from center have less access to CART.
N Ahmed, E Shippey, C Kus, A Appenfeller, MS Hoffmann, AM Tun, ...
Journal of Clinical Oncology 39 (15_suppl), e18562-e18562, 2021
32021
Risks of upper respiratory tract infection and pneumonia in patients with multiple myeloma receiving Daratumumab: A systematic review and meta-analysis of randomized controlled …
K Ticona, A Tun, E Guevara
Journal of Clinical Oncology 36 (15_suppl), e20005-e20005, 2018
32018
The system can't perform the operation now. Try again later.
Articles 1–20